The PE Ratio as of November 2024 (TTM) for Tenax Therapeutics, Inc. (TENX) is -0.38

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.38. This represents a change of -137.91% compared to the average of 1.00 of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical PE Ratio (quarterly & annually)

How has TENX PE Ratio performed in the past?

The mean historical PE Ratio of Tenax Therapeutics, Inc. over the last ten years is -84.28. The current -0.38 PE Ratio has changed -54.91% with respect to the historical average. Over the past ten years (40 quarters), TENX's PE Ratio was at its highest in in the September 2024 quarter at 4.62. The PE Ratio was at its lowest in in the April 2015 quarter at -385.64.

Tenax Therapeutics, Inc. (TENX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenax Therapeutics, Inc. (TENX) Average PE Ratio

How has TENX PE Ratio performed in the past?

The current PE Ratio of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tenax Therapeutics, Inc. (TENX) PE Ratio vs. Peers

How is TENX’s PE Ratio compared to its peers?

Tenax Therapeutics, Inc.’s PE Ratio is less than Allarity Therapeutics, Inc. (-0.10), greater than NeuroBo Pharmaceuticals, Inc. (-0.87), greater than Hillstream BioPharma, Inc. (-0.99), greater than Virax Biolabs Group Limited (-0.67), less than Quoin Pharmaceuticals, Ltd. (-0.33), less than Blue Water Vaccines, Inc. (-0.26), less than PaxMedica, Inc. Common Stock (-0.04), less than Revelation Biosciences, Inc. (-0.13), less than ZyVersa Therapeutics, Inc. (-0.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-1.88), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Altamira Therapeutics Ltd. (-0.03), less than Windtree Therapeutics, Inc. (-0.03), less than Dermata Therapeutics, Inc. (-0.16), greater than Ensysce Biosciences, Inc. (-0.54), less than Panbela Therapeutics, Inc. (-0.06), less than Baudax Bio, Inc. (-0.16), less than Aditxt, Inc. (-0.00), greater than Unicycive Therapeutics, Inc. (-1.63),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.